United Therapeutics (UTHR) Change in Acquisitions & Divestments (2009 - 2026)

United Therapeutics has reported Change in Acquisitions & Divestments for 18 years, with the latest figure at $1.3 billion in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 113.81% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 billion (up 135.5% YoY) and the FY2025 annual result came in at $1.6 billion, up 90.42% from the prior year.
• Change in Acquisitions & Divestments grew to $1.3 billion in Q1 2026 per UTHR's latest filing, from $485.5 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $2.1 billion in Q4 2023 and troughed at -$506.6 million in Q3 2022.
• A 5-year average of $529.4 million and a median of $378.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• The widest YoY moves for Change in Acquisitions & Divestments: up 693.26% in 2022, down 152.86% in 2022.
• Over 5 years, Change in Acquisitions & Divestments stood at $1.0 billion in 2022, then surged by 110.01% to $2.1 billion in 2023, then tumbled by 92.51% to $160.0 million in 2024, then soared by 203.44% to $485.5 million in 2025, then jumped by 169.39% to $1.3 billion in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $1.3 billion, $485.5 million, and $182.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.